Cargando…
Cholestatic Jaundice Induced by Duloxetine in a Patient with Major Depressive Disorder
Duloxetine is a balanced and potent serotonin and noradrenaline reuptake inhibitor (SNRI) and has adverse effects that are commonly associated with such drugs, including nausea, dry mouth, constipation, insomnia, and dizziness. Recently, duloxetine-induced liver injury has also been observed in pati...
Autores principales: | Park, Young-Min, Lee, Bun-Hee, Lee, Heon-Jeong, Kang, Seung-Gul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947813/ https://www.ncbi.nlm.nih.gov/pubmed/20927314 http://dx.doi.org/10.4306/pi.2010.7.3.228 |
Ejemplares similares
-
Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2011) -
Trifluoperazine-Induced Cholestatic Jaundice
por: Sharifi, Vandad, et al.
Publicado: (2010) -
Cephalexin Induced Cholestatic Jaundice
por: Agrawal, Abhinav, et al.
Publicado: (2014) -
Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007) -
Severe cholestatic jaundice associated with Graves’ disease
por: Abebe, Abebe, et al.
Publicado: (2018)